ProPhase Labs (NASDAQ: PRPH) reported Q3 EPS of ($0.26), $0.33 worse than the analyst estimate of $0.07. Revenue for the quarter came in at $9.5 million versus the consensus estimate of $9.08 million.

For earnings history and earnings-related data on ProPhase Labs (PRPH) click here.